No additional AE/No symptoms reported; HCP calling regarding GARDASIL-9 dosing schedule for a 13 year old female patient. Caller stated that the third dose was administered a “little after” 6 months.; This spontaneous report was received from a consumer and refers to a 13-year-old female patient. The patient’s medical history was not reported. The patient’s concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date and on an unknown date in 2024, the patient was vaccinated with the first and second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided), respectively. On 21-JAN-2025, the patient was vaccinated with the third dose of rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, lot #W026152, expiration date: 29-JAN-2025, administered for prophylaxis (strength, and route of administration were not provided). Reporter stated that this third dose was administered a “little after” 6 months (Inappropriate schedule of product administration). No symptoms reported. No further information was provided. Lot # is being requested and will be submitted if received.